InterventionsHumans

BMI Regain and Blood-Pressure Change after Discontinuation of Antiobesity Agents

ADA Scientific Sessions 2025 Abstract

The paper

Kibum Kim, Lilah Khoja, Ebere Okpara

Chicago

ADA Scientific Sessions 2025 Abstract · 13 Jun 2025

Presented at ADA Scientific Sessions 2025 · Late-breaking 2197-LB

doi.org/10.2337/db25-2197-lb

GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026